SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (4925)11/28/1997 10:28:00 PM
From: aknahow  Read Replies (1) | Respond to of 17367
 
Chlamydia pneumoniae gene sequenced C.P. implicated in causing coronary artery disease. If this helps demonstrate it does then implications for Xoma. Job positions indicate XOMA was seeking scientest with experience in this area.

biz.yahoo.com

Remember wildrose site. In March issue discussed EntreMed (?) as well as XOMA. This is really a nice site. Glad Andy did not tell me about the stock as I would have ignored it and really been disapointed.<g>



To: Robert K. who wrote (4925)11/28/1997 11:27:00 PM
From: aknahow  Read Replies (2) | Respond to of 17367
 
Bob, Medline has a few (3) new abstracts. Last is Giroir and Meningococcemia. Contains alternative methods of measurig mortality. XOMA site uses lowest number (20%). Don't recall seeing this info in on line Lancet summary but perhaps it was. The Medline abstract is also from Lancet. Sure you have seen these, just mentioning for anyone else.

BTW my order did not fill.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News